Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-30

Clinical Trial Update: Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating curcumin for cervical intraepithelial neoplasia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Baylor Research Institute | Conditions: Cervical Intraepithelial Neoplasia | EARLY_Phase 1 | Status: WITHDRAWN